Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Paramount Bed Holdings Co's Net Cash per Share or its related term are showing as below:
During the past 13 years, the highest Price-to-Net-Cash Ratio of Paramount Bed Holdings Co was 1685.06. The lowest was 9.16. And the median was 14.82.
PBHDF's Price-to-Net-Cash is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 8.725 * Ranked among companies with meaningful Price-to-Net-Cash only.
Paramount Bed Holdings Co (OTCPK:PBHDF) Net Cash per Share Explanation
Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.
You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.
Paramount Bed Holdings Co Net Cash per Share Related Terms
Paramount Bed Holdings Co Net Cash per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Paramount Bed Holdings Co Net Cash per Share Chart
PBHDF vs ISRG, BDX, MDLN: Net Cash per Share Comparison
For the Medical Instruments & Supplies subindustry, Paramount Bed Holdings Co's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Paramount Bed Holdings Co Price-to-Net-Cash vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Paramount Bed Holdings Co's Price-to-Net-Cash distribution charts can be found below:
* The bar in red indicates where Paramount Bed Holdings Co's Price-to-Net-Cash falls into.
Paramount Bed Holdings Co Net Cash per Share Calculation
In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.
Paramount Bed Holdings Co's Net Cash per Share for the fiscal year that ended in Mar. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Paramount Bed Holdings Co (PBHDF) has a Net Cash per Share of $-0.04 as of Sep. 2025. Net cash per share equals the per-share value of cash and equivalents less total liabilities and minority interest. View historical data on Paramount Bed Holdings Co and its competitors. Over the past decade, Paramount Bed Holdings Co's Net Cash per Share has ranged from 9.16 to 1,685.06.
Is Paramount Bed Holdings Co's Net Cash per Share too high?
Paramount Bed Holdings Co's current Net Cash per Share is $-0.04. Over the past 10 years, this metric has ranged from a low of 9.16 to a high of 1,685.06. Overall, Paramount Bed Holdings Co has a GF Score™ of 90/100, reflecting its overall financial health beyond just this single metric.
How does Paramount Bed Holdings Co's Net Cash per Share compare to ISRG and BDX?
Paramount Bed Holdings Co's Net Cash per Share of $-0.04 can be compared against companies in the Medical Devices & Instruments industry. The industry median Net Cash per Share is 8.73. Historically, Paramount Bed Holdings Co's own Net Cash per Share has ranged from 9.16 to 1,685.06 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Cash per Share for a Medical Devices & Instruments company?
The median Net Cash per Share among Medical Devices & Instruments companies is 8.73, based on 302 companies in the industry. Companies in the top quartile (top 25%) have a Net Cash per Share significantly above this median, while those in the bottom quartile fall well below. However, Net Cash per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Cash per Share mean?
A high Net Cash per Share can signal that a stock is expensive relative to its fundamentals. Net cash per share equals the per-share value of cash and equivalents less total liabilities and minority interest. View historical data on Paramount Bed Holdings Co and its competitors. For the Medical Devices & Instruments industry, the median Net Cash per Share is 8.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Paramount Bed Holdings Co's current Net Cash per Share is $-0.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Paramount Bed Holdings Co stock overvalued right now?
Paramount Bed Holdings Co (PBHDF) has a current Net Cash per Share of $-0.04. The stock's GF Value™ is $16.33, compared to a current price of $19.74 — trading 20.9% above its estimated fair value. The current Net Cash per Share is $-0.04. Paramount Bed Holdings Co's overall GF Score™ is 90/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Cash per Share calculated?
Net Cash per Share is calculated from a company's financial statements. For Paramount Bed Holdings Co (PBHDF), the current Net Cash per Share is $-0.04 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Paramount Bed Holdings Co (PBHDF) Overvalued in 2026?
Based on GuruFocus' analysis, Paramount Bed Holdings Co stock appears to be overvalued.
The current stock price of $19.74 is trading 20.9% above its estimated GF Value™ of $16.33.
Key valuation signals for PBHDF:
Net Cash per Share: $-0.04
GF Value™: $16.33 vs. price of $19.74 (20.9% above fair value)
No single metric tells the full story. See the PBHDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Paramount Bed Holdings Co Ltd manufactures medical and nursing care products. Its acute care business sells products to intensive care units and other acute care facilities to relieve patient discomfort and prevent secondary infections. The long-term care business sells products used at long-term medical care facilities and nursing homes. The residential and nursing care business sells products to nurses and home-care helpers. The sleep and wellness business sells products to help customers sleep soundly, which include custom-made mattresses. The maintenance business provides bed maintenance and cleaning services. Paramount Bed generates the vast majority of its revenue in Japan.
90GF Score
Get the complete analysis for PBHDF
Net Cash per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PBHDF has been successfully added to your 
